The intricate mechanisms behind dry eye disease have led to the development of targeted therapeutic agents, among which P2Y2 receptor agonists have emerged as a significant class. For procurement managers and R&D scientists, understanding the function and sourcing of these compounds, such as Diquafosol Tetrasodium, is crucial. As a dedicated manufacturer of fine chemicals, we are committed to providing high-quality P2Y2 receptor agonists that empower advancements in ocular health.

Diquafosol Tetrasodium (CAS 211427-08-6) acts as a potent P2Y2 receptor agonist. These receptors are widely distributed on the ocular surface, including conjunctival goblet cells and corneal epithelial cells. Activation of P2Y2 receptors by agonists like Diquafosol Tetrasodium triggers a cascade of events that stimulate the secretion of essential tear film components, notably mucins and aqueous fluid. This enhanced secretion is vital for restoring tear film stability, reducing evaporation, and alleviating the discomfort associated with dry eye disease. When considering the purchase of such specialized compounds, verifying the supplier's expertise and product quality is essential.

The therapeutic benefits are well-documented. Clinical studies have shown that Diquafosol Tetrasodium can significantly improve corneal staining scores and relieve subjective symptoms such as foreign body sensation. Its ability to enhance the lipid layer thickness of tears also contributes to overall ocular surface health. This makes it a cornerstone ingredient for companies developing innovative treatments for evaporative dry eye and meibomian gland dysfunction. As a supplier, we ensure that our Diquafosol Tetrasodium meets the high purity (≥99%) and standard requirements (USP, BP, EP) demanded by the pharmaceutical industry.

For businesses looking to incorporate this vital compound into their product pipelines, understanding the global price landscape and identifying reliable manufacturing partners is key. China has established itself as a significant hub for the production of fine chemicals and pharmaceutical intermediates. By choosing a reputable Chinese manufacturer, you can often benefit from cost-effectiveness without compromising on quality. We encourage you to reach out for a personalized quote, as bulk orders may offer additional savings for your enterprise. Exploring online purchase platforms can also provide efficient access to verified suppliers.

In conclusion, the role of P2Y2 receptor agonists in modern dry eye treatment is undeniable. Diquafosol Tetrasodium represents a prime example of a compound that directly addresses the underlying physiological deficits of dry eye. We invite you to explore our offerings and experience the advantages of sourcing from a committed and quality-driven manufacturer. Contact us to learn more about how our Diquafosol Tetrasodium can support your research and product development goals.